AUTHOR=Efthymiou Stephanie , Han Wenyan , Ilyas Muhammad , Li Jun , Yu Yichao , Scala Marcello , Malintan Nancy T. , Ilyas Muhammad , Vavouraki Nikoleta , Mankad Kshitij , Maroofian Reza , Rocca Clarissa , Salpietro Vincenzo , Lakhani Shenela , Mallack Eric J. , Palculict Timothy Blake , Li Hong , Zhang Guojun , Zafar Faisal , Rana Nuzhat , Takashima Noriko , Matsunaga Hayato , Manzoni Claudia , Striano Pasquale , Lythgoe Mark F. , Aruga Jun , Lu Wei , Houlden Henry TITLE=Human mutations in SLITRK3 implicated in GABAergic synapse development in mice JOURNAL=Frontiers in Molecular Neuroscience VOLUME=17 YEAR=2024 URL=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2024.1222935 DOI=10.3389/fnmol.2024.1222935 ISSN=1662-5099 ABSTRACT=

This study reports on biallelic homozygous and monoallelic de novo variants in SLITRK3 in three unrelated families presenting with epileptic encephalopathy associated with a broad neurological involvement characterized by microcephaly, intellectual disability, seizures, and global developmental delay. SLITRK3 encodes for a transmembrane protein that is involved in controlling neurite outgrowth and inhibitory synapse development and that has an important role in brain function and neurological diseases. Using primary cultures of hippocampal neurons carrying patients’ SLITRK3 variants and in combination with electrophysiology, we demonstrate that recessive variants are loss-of-function alleles. Immunostaining experiments in HEK-293 cells showed that human variants C566R and E606X change SLITRK3 protein expression patterns on the cell surface, resulting in highly accumulating defective proteins in the Golgi apparatus. By analyzing the development and phenotype of SLITRK3 KO (SLITRK3–/–) mice, the study shows evidence of enhanced susceptibility to pentylenetetrazole-induced seizure with the appearance of spontaneous epileptiform EEG as well as developmental deficits such as higher motor activities and reduced parvalbumin interneurons. Taken together, the results exhibit impaired development of the peripheral and central nervous system and support a conserved role of this transmembrane protein in neurological function. The study delineates an emerging spectrum of human core synaptopathies caused by variants in genes that encode SLITRK proteins and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired postsynaptic neurotransmission at nerve terminals; an impaired neurotransmission resulting in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by SLITRK3 mutations highlights the key roles of this gene in human brain development and function.